JPRN-C000000051已完成1 期
A phase I/II study of hepatic arterial 5-flurouracil (5FU) combined with intravenous irinotecan hydrochloride (CPT-11) for metastatic colorectal cancer isolated in the liver. (JCOG 0208-DI) - A phase I/II study of hepatic arterial 5FU combined with intravenous CPT-11 for metastatic colorectal cancer isolated in the liver. (JCOG 0208-DI)
Japan Clinical Oncology Group(JCOG)0 个研究点目标入组 30 人开始时间: 2005年8月8日最近更新:
适应症
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 发起方
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 70years-old(—)
- 性别
- All
入选标准
- 未提供
排除标准
- •1) Massive pleural effusion or massive ascites. 2) Active bleeding from digestive organ. 3) Active infection. 4) Watery diarrhea. 5) Other uncontrolled severe illness. 6) Active other malignancy. 7) Prior radiation therapy for abdomen. 8) Positive hepatitis-B antigen or anti-hepatitis-C antibody. 9) Allergy to iodine contrast medium resulting in preclusion of angiography. 10) Severe mental disorder. 11) Pregnant or nursing. 12) Prior placement of hepatic arterial catheter and port system.
研究者
相似试验
已完成
2 期
Randomized Phase II Study of 5-fluorouracil Hepatic Arterial Infusion With or Without Antineoplastons as an Adjuvant Therapy After Hepatectomy for Liver Metastases from Colorectal Canceriver Metastases from Colorectal CancerJPRN-UMIN000012099Kurume University School of Medicine50
已完成
1 期
Phase I/II study of arterial infusion of 5-fluorouracil combined with systemic gemcitabine for unresectable pancreatic cancernresectable pancreatic cancerJPRN-UMIN000000573ara Medical University24
已完成
1 期
Phase I/II trial of hepatic arterial infusion of FMP therapy for advanced hepatocellular carcinomaadvanced hepatocellular carcinomaJPRN-UMIN000000487Hepatobiliary and Pancreatic Oncology Division, National Cancer Center Hospital45
已完成
2 期
pilot study of intraarterial 5-fluorouracil/interferon combination therapy for advanced hepatocellular carcinoma patients who do not response to intraarterial 5-fluorouracil/cisplatin combination therapy.advanced hepatocellular caricinomaJPRN-UMIN000002928Department of Medicine and Molecular Science, Division of Frontier Medical Science, Programs for Biomedical Research, Graduate School of Biomedical, Hiroshima University20
尚未招募
不适用
Comparison of intralesional 5-fluorouracil with MMR vaccine in wartsCTRI/2023/12/060907Department of Dermatology
